High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$6.0M
$5,951,051
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
TNYA
S
Tenaya Therapeutics, Inc.
COLUMN GROUP III GP, LP
• 10% Owner
Discretionary Sell
2026-02-25
$1,975,051Largex2
|
||||||
| TNYA |
Tenaya Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2026-02-25 | $1,975,051Largex2 | S | Form 4 |
|
TNYA
S
Tenaya Therapeutics, Inc.
COLUMN GROUP III GP, LP
• 10% Owner
Discretionary SellΔOwn -15.8%
2026-02-24
$405,138x2
|
||||||
| TNYA |
Tenaya Therapeutics, Inc.
|
10% Owner
Discretionary SellΔOwn -15.8%
|
2026-02-24 | $405,138x2 | S | Form 4 |
|
TNYA
S
Tenaya Therapeutics, Inc.
COLUMN GROUP III GP, LP
• 10% Owner
Discretionary Sell
2026-02-23
$182,743x2
|
||||||
| TNYA |
Tenaya Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2026-02-23 | $182,743x2 | S | Form 4 |
|
TNYA
S
Tenaya Therapeutics, Inc.
COLUMN GROUP III GP, LP
• 10% Owner
Discretionary SellΔOwn -10.5%
2026-02-20
$322,044x2
|
||||||
| TNYA |
Tenaya Therapeutics, Inc.
|
10% Owner
Discretionary SellΔOwn -10.5%
|
2026-02-20 | $322,044x2 | S | Form 4 |
| TNYA |
Tenaya Therapeutics, Inc.
|
CEO
Sell to Cover
|
2026-02-17 | $9,557x3 | S | Form 4 |
|
TNYA
S
Tenaya Therapeutics, Inc.
Higa Tomohiro
• Officer • SVP, Finance
Sell to Cover
2026-02-17
$2,231x3
|
||||||
| TNYA |
Tenaya Therapeutics, Inc.
|
Officer • SVP, Finance
Sell to Cover
|
2026-02-17 | $2,231x3 | S | Form 4 |
|
TNYA
S
Tenaya Therapeutics, Inc.
Tingley Whittemore
• Officer • Chief Medical Officer
Sell to Cover
2026-02-17
$2,263x2
|
||||||
| TNYA |
Tenaya Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-02-17 | $2,263x2 | S | Form 4 |
|
TNYA
S
Tenaya Therapeutics, Inc.
COLUMN GROUP III GP, LP
• 10% Owner
Discretionary SellΔOwn -44.8%
2026-02-11
$2,761,715Largex2
|
||||||
| TNYA |
Tenaya Therapeutics, Inc.
|
10% Owner
Discretionary SellΔOwn -44.8%
|
2026-02-11 | $2,761,715Largex2 | S | Form 4 |
|
TNYA
S
Tenaya Therapeutics, Inc.
COLUMN GROUP III GP, LP
• 10% Owner
Discretionary Sell
2026-02-10
$280,507x2
|
||||||
| TNYA |
Tenaya Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2026-02-10 | $280,507x2 | S | Form 4 |
| TNYA |
Tenaya Therapeutics, Inc.
|
CEO
Sell to Cover
|
2025-11-17 | $4,158 | S | Form 4 |
|
TNYA
S
Tenaya Therapeutics, Inc.
Higa Tomohiro
• Officer • SVP, Finance
Sell to Cover
2025-11-17
$1,818
|
||||||
| TNYA |
Tenaya Therapeutics, Inc.
|
Officer • SVP, Finance
Sell to Cover
|
2025-11-17 | $1,818 | S | Form 4 |
|
TNYA
S
Tenaya Therapeutics, Inc.
Tingley Whittemore
• Officer • Chief Medical Officer
Sell to Cover
2025-11-17
$3,826
|
||||||
| TNYA |
Tenaya Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-11-17 | $3,826 | S | Form 4 |